VARIVAX II
VARIVAX II
Discontinued
DIN Number
02240776
Drug Class
Human
Market Date
Jun 27, 2000
Company
HC
merck frosst canada & cie, merck frosst canada & co.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02240776
AIG Number0152480001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J07BK01 VARICELLA, LIVE ATTENUATED
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationSubcutaneous
AHFS Classification80:12.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
VARICELLA-ZOSTER VIRUS VACCINE LIVE ATTENUATED (OKA/MERCK STRAIN)Active
Strength: 1350 UNIT / DOSE
Monograph: VARICELLA-ZOSTER VIRUS VACCINE LIVE ATTENUATED (OKA/MERCK STRAIN)